These data suggest that CSCs are not a single entity and that distinct EpCAM+ and CD90+ CSCs could collaborate to orchestrate tumor progression and metastasis, suggesting that both EpCAM+ and CD90+ CSCs should be eradicated in the treatment of HCC8. The gene discussed is EPCAM; the disease is neoplasm.